SAM
TPTX

Sectoral Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Sectoral Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-90,000
Closed -$6.77M – 121
2022
Q2 		$6.77M Sell
90,000
-190,850
-68% -$8.48M 1.36% 24
2022
Q1 		$7.54M Buy
280,850
+61,100
+28% +$2.05M 1.34% 28
2021
Q4 		$10.5M Buy
219,750
+83,100
+61% +$3.72M 1.58% 21
2021
Q3 		$9.08M Sell
136,650
-75,000
-35% -$5.34M 0.76% 54
2021
Q2 		$16.5M Sell
211,650
-46,229
-18% -$3.42M 1.34% 25
2021
Q1 		$24.4M Buy
257,879
+500
+0.2% +$59.5K 1.85% 12
2020
Q4 		$31.4M Buy
257,379
+6,898
+3% +$756K 2.21% 14
2020
Q3 		$21.9M Sell
250,481
-34,005
-12% -$2.37M 1.88% 20
2020
Q2 		$18.4M Buy
284,486
+166,686
+141% +$9.62M 1.69% 19
2020
Q1 		$5.26M Buy
+117,800
New +$6.26M 1.01% 45

Sectoral Asset Management's TPTX Position: Q3 2022 in Review

Sectoral Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 90,000 shares — an estimated $6.77M sold.

Sectoral Asset Management first reported a position in TPTX in Q1 2020 and held it in 10 quarters. The position peaked at $31.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Sectoral Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 90,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $6.77M.
  • Sectoral Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Sectoral Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $31.4M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.